Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000229768 | SCV000286058 | likely benign | Rhabdoid tumor predisposition syndrome 2 | 2024-01-15 | criteria provided, single submitter | clinical testing | |
Genetic Services Laboratory, |
RCV000501862 | SCV000597190 | likely benign | not specified | 2016-01-22 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000568040 | SCV000664002 | likely benign | Hereditary cancer-predisposing syndrome | 2015-10-10 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Sema4, |
RCV000568040 | SCV002532924 | likely benign | Hereditary cancer-predisposing syndrome | 2021-05-21 | criteria provided, single submitter | curation | |
Quest Diagnostics Nichols Institute San Juan Capistrano | RCV002478845 | SCV002774240 | likely benign | not provided | 2023-06-28 | criteria provided, single submitter | clinical testing |